StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
CNXUConexeu Sciences Inc.
stockpulse.co.kr
Nasdaq
$3.31▲ 6.77%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $88.6MShares out 26.8M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

20
  • 4d agoPre-market26.10.21 10:12filed
    DOther#●●●

    Conexeu Sciences Inc.

    Conexeu Sciences Inc. filed a Form D with the SEC on October 21, 2026, regarding an exempt offering of securities. The filing pertains to the company's capital raising activities, though specific terms and the total amount of the offering were not disclosed.…more

    $3.31+6.77%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 4d agoPre-market26.10.21 07:37filed
    424B3Offering

    Conexeu Sciences Inc.

    Conexeu Sciences raised capital through the issuance of 4,741,660 shares of common stock between September 14 and October 15, 2026, via private placements and warrant exercises. On October 15, 2026, the company raised $3,999,999 by issuing 1,333,333 units at $3.00 per unit, while an additional 83,334 units for management and directors remain in escrow pending shareholder approval. This issuance results in dilution for existing shareholders, and the company is obligated to file an S-1 registration statement for the resale of these securities.…more

    $3.31+6.77%vs prev close
    View filingShare
  • 4d agoAfter-hours26.10.21 05:30
    8-KKey event

    Conexeu Sciences Inc.

    Conexeu Sciences completed a private placement on October 15, 2026, raising $3,999,999 through the issuance of 1,333,333 units at $3.00 per unit. The company also secured additional funding through a $250,002 issuance to management and directors, pending shareholder approval, and a $750,000 special warrant issuance. These transactions will result in share dilution, and the company is committed to filing an S-1 registration statement for the resale of these securities.…more

    $3.31+6.77%vs prev close
    View filingShare

19 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 10.15After-hours26.10.16 05:30
    Bullish#●●●#●●●#●●●

    Conexeu Sciences Secures $5 Million in Private Placement

    Conexeu Sciences has closed a $5 million private placement to fund manufacturing scale-up and regulatory testing for its medical device platform. The capital supports the company's goal to submit an FDA 510(k) application in the first quarter of 2027.…more

    $3.31+6.77%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    Read sourceShareGlobeNewswire
  • 10.6Pre-market26.10.06 21:30

    ●●●●●●●● ●●●●● ●●●●●●

    Conexeu Sciences is advancing its 'Ten Minute Tissue' wound care device toward a planned FDA 510(k) submission in the first quarter of 2027. The company has successfully scaled up manufacturing processes and is currently conducting the regulatory testing required for commercialization.…more

    $3.31+6.77%vs prev close
    Read sourceShareGlobeNewswire
  • 9.1Pre-market26.09.01 21:30

    ●●●●●●●● ●●●●● ●●●●●●

    Preclinical-stage biotech company Conexeu Sciences will participate in several investor conferences throughout September and October. These events serve as opportunities for management to engage with stakeholders regarding the company's progress, though no specific commercial agreements were announced.…more

    $3.31+6.77%vs prev close
    Read sourceShareGlobeNewswire

2 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →